1. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial. Issue 1 (January 2022) Authors: Verma, Subodh; Dhingra, Nitish K; Butler, Javed; Anker, Stefan D; Ferreira, Joao Pedro; Filippatos, Gerasimos; Januzzi, James L; Lam, Carolyn S P; Sattar, Naveed; Peil, Barbara; Nordaby, Matias; Brueckmann, Martina; Pocock, Stuart J; Zannad, Faiez; Packer, Milton; Packer, M; Anker, S; Butler, J; ... Journal: Lancet Issue: Volume 10:Issue 1(2022) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. G403(P) Attention after paedaitric stroke: A systematic review. (24th May 2017) Authors: Balfour, P; Kawadler, J; Kirkham, FJ Journal: Archives of disease in childhood Issue: Volume 102(2017)Supplement 1 Page Start: A158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. G98 Attention deficits in paediatric sickle cell disease; links with nocturnal oxygen desaturation in adolescents, but not children. (24th May 2017) Authors: Stotesbury, H; Kirkham, FJ; Balfour, P; Koelbel, M; Inusa, B; Chakraborty, S; Rees, DC; Downes, M; Kawadler, J Journal: Archives of disease in childhood Issue: Volume 102(2017)Supplement 1 Page Start: A40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗